Skip to main content
. 2015 Jul 29;35(30):10821–10830. doi: 10.1523/JNEUROSCI.0575-15.2015

Figure 4.

Figure 4.

VSL#3 treatment reduces circulating TNF-α levels in BDL mice. Plasma TNF-α and G-CSF levels as determined using Luminex technology for placebo- or VSL#3-treated sham and BDL mice. All data are represented as mean ± SEM, n = 6–8/group, *p < 0.05, **p < 0.01, ***p < 0.001.